BEIJING TONG REN TANG CHINESE MEDICINE COMPANY LIMITED

Beijing Tong Ren Tang Chinese Medicine Company Limited

3613

HK0000145638

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 09:08:22 10/05/2024 BST			5-day change	1st Jan Change
10.16 ^HKD	+2.32%		+8.20%	-16.31%

05-10	Beijing Tong Ren Tang Chinese Medicine Company Limited Appoints Wang Chi as an Executive Director and a Member of the Competition Executive Committee	CI
05-10	Beijing Tong Ren Tang Chinese Medicine Company Limited Announces CEO Changes	CI

Beijing Tong Ren Tang Chinese Medicine Company Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 24 June 2024

March 14, 2024 at 01:06 pm

Beijing Tong Ren Tang Chinese Medicine Company Limited proposed final dividend of HKD 0.33 per share for the Year Ended 31 December 2023. Record date is 18 June 2024, Payment date is 24 June 2024 and Ex-dividend date is 12 June 2024. Date of shareholders' approval is 07 June 2024.

Latest news about Beijing Tong Ren Tang Chinese Medicine Company Limited

Beijing Tong Ren Tang Chinese Medicine Company Limited Appoints Wang Chi as an Executive Director and a Member of the Competition Executive Committee	05-10	CI
Beijing Tong Ren Tang Chinese Medicine Company Limited Announces CEO Changes	05-10	CI
Beijing Tong Ren Tang Gets Nod to Sell Fever Drug in Hong Kong	04-30	MT
Beijing Tong Ren Tang Chinese Medicine Company Limited Announcement on Receiving the Certificate of Registration of Proprietary Chinese Medicine	04-30	CI
Beijing Tong Ren Tang Chinese Medicine CEO Steps Down; Acting CEO Appointed	03-29	MT
Beijing Tong Ren Tang Chinese Medicine Company Limited Announces CEO Changes	03-28	CI
Beijing Tong Ren Tang Chinese Medicine Company Limited Announces Resignation of Yu Jin as an Executive Director and Member of the Competition Executive Committee	03-28	CI
Beijing Tong Ren Tang Chinese Medicine's Profit Falls on Lower Revenue	03-15	MT
Beijing Tong Ren Tang Chinese Medicine Signs E-Commerce Framework Agreement	03-15	MT
Beijing Tong Ren Tang Chinese Medicine Company Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 24 June 2024	03-14	CI
Beijing Tong Ren Tang Chinese Medicine Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	03-14	CI
Beijing Tong Ren Tang Flags Up to 22% Profit Drop in 2023	01-29	MT
Beijing Tong Ren Tang Chinese Medicine Company Limited Provides Earnings Guidance for the Year Ended 31 December 2023	01-29	CI
Beijing Tong Ren Tang Appoints Chairman	12-13	MT
Beijing Tong Ren Tang Chinese Medicine Company Limited Appoints Gu Hai Ou as Executive Director, Chairman of Board and Authorised Representative	12-13	CI
Beijing Tong Ren Tang to Vote Dec. 27 on Renewal of Distributorship Contracts	12-05	MT
Beijing Tong Ren Tang Chinese Medicine Company Limited Proposes New Exclusive Distributorship Framework Agreements	11-29	CI
Chinese listed firms used endangered animal parts as ingredients -report	23/10/23	RE
Three listed Chinese firms used endangered animal parts as ingredients- report	23/10/23	RE
Beijing Tong Ren Tang Chinese Medicine Company Limited Appoints Mr. Yu Jin as Executive Director and A Member of Competition Executive Committee	20/10/23	CI
Sinopharm CFO Retires; Successor Named	16/10/23	MT
Beijing Tong Ren Tang Chinese Medicine COO Resigns	13/09/23	MT
Beijing Tong Ren Tang Chinese Medicine Company Limited Announces Resignation of Lin Man as Executive Director, Chief Operating Officer, Member of Competition Executive Committee	12/09/23	CI
Beijing Tong Ren Tang Chinese Medicine Company Limited Announces Retirement of Ding Yong Ling as Executive Director and Chairman of the Board	31/08/23	CI
Beijing Tong Ren Tang's Profit Jumps 23.9% in H1	11/08/23	MT

Chart Beijing Tong Ren Tang Chinese Medicine Company Limited

Duration

Period

Chart Beijing Tong Ren Tang Chinese Medicine Company Limited

More charts

Company Profile

Beijing Tong Ren Tang Chinese Medicine Company Limited is a company mainly engaged in the manufacturing and sale of Chinese medicine. Along with subsidiaries, it operates its business through three segments. The Hong Kong segment engages in the sale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments through retail outlets as well as wholesale of Chinese medicine products in Hong Kong. It is also involved in the royalty fee income from overseas entities using the brand of Tong Ren Tang. The Mainland China segment engages in the wholesale of healthcare products in Mainland China and the sole distribution of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd. to customers outside Mainland China. The Overseas segment engages in the retail and wholesale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments in other overseas countries.

Sector

Pharmaceuticals

Calendar

07/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Beijing Tong Ren Tang Chinese Medicine Company Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

10.16 HKD

Average target price

13.92 HKD

Spread / Average Target

+37.06%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BEIJING TONG REN TANG CHINESE MEDICINE COMPANY LIMITED	-16.31%	1.09B
ELI LILLY AND COMPANY	+30.38%	684B
NOVO NORDISK A/S	+26.51%	568B
JOHNSON & JOHNSON	-4.36%	361B
MERCK & CO., INC.	+19.30%	329B
ABBVIE INC.	+3.73%	284B
ASTRAZENECA PLC	+16.70%	240B
NOVARTIS AG	+8.78%	208B
ROCHE HOLDING AG	-7.93%	200B
AMGEN INC.	+7.68%	166B

Other Pharmaceuticals